Search

everythinglearnresearchcommunity

for

Search:↓

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

3D imaging effectively tracks skin changes in vitiligo treatment.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

The combination therapy was effective and well-tolerated, especially in young patients.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Clascoterone safely promotes hair growth similar to minoxidil.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

Topical 1% sildenafil is not recommended for treating alopecia areata in children.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Standardized treatment protocols are needed for children with androgenetic alopecia.

The treatment was effective for lupus nephritis with manageable side effects.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.